| Vitiligo |
0 |
1 |
| Dermatitis |
0 |
0.86 |
| Acne |
0 |
0.23 |
| Adverse Effects |
0 |
0.07 |
| Atopic Dermatitis |
0 |
0.07 |
| Bullying |
0 |
0.07 |
| Cancer |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Dermatopathology |
0 |
0.07 |
| Face |
0 |
0.07 |
| Fever |
0 |
0.07 |
| Food and Drug Administration (FDA) |
0 |
0.07 |
| Headache |
0 |
0.07 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Patient Safety |
0 |
0.07 |
| Pruritus |
0 |
0.07 |
| Quality of Life |
0 |
0.07 |
| Skin and Soft Tissue Infection |
0 |
0.07 |
| Steroids |
0 |
0.07 |
| Thromboembolism |
0 |
0.07 |
| Thrombosis |
0 |
0.07 |
| Urinary Tract Infection |
0 |
0.07 |